Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.

Delvino P, Quartuccio L, Robson JC, Ferretti VV, Klersy C, Alberici F, Bagnasco D, Berti A, Caminati M, Camoni M, Cid MC, Conticini E, Costanzo G, de Moreuil C, Del Giacco S, Espigol-Frigole G, Franceschini F, Iorio L, Kernder A, Lo Gullo A, Losappio L, Manna E, Maule M, Milanesi A, Montecucco C, Negrini S, Padoan R, Regola F, Ricciardi L, Schroeder J, Terrier B, Toniati P, Torracca F, Treppo E, Urban ML, Vaglio A, Emmi G, Monti S, European EGPA Study Group.

Open source

DOI
10.1093/rheumatology/keaf232
Published
2025-09-01
Container
Rheumatology (Oxford)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keaf232,
  title = {Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.},
  author = {Delvino P and  Quartuccio L and  Robson JC and  Ferretti VV and  Klersy C and  Alberici F and  Bagnasco D and  Berti A and  Caminati M and  Camoni M and  Cid MC and  Conticini E and  Costanzo G and  de Moreuil C and  Del Giacco S and  Espigol-Frigole G and  Franceschini F and  Iorio L and  Kernder A and  Lo Gullo A and  Losappio L and  Manna E and  Maule M and  Milanesi A and  Montecucco C and  Negrini S and  Padoan R and  Regola F and  Ricciardi L and  Schroeder J and  Terrier B and  Toniati P and  Torracca F and  Treppo E and  Urban ML and  Vaglio A and  Emmi G and  Monti S and  European EGPA Study Group.},
  year = {2025},
  journal = {Rheumatology (Oxford)},
  doi = {10.1093/rheumatology/keaf232},
  url = {https://doi.org/10.1093/rheumatology/keaf232}
}

RIS

TY  - JOUR
TI  - Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.
AU  - Delvino P
AU  -  Quartuccio L
AU  -  Robson JC
AU  -  Ferretti VV
AU  -  Klersy C
AU  -  Alberici F
AU  -  Bagnasco D
AU  -  Berti A
AU  -  Caminati M
AU  -  Camoni M
AU  -  Cid MC
AU  -  Conticini E
AU  -  Costanzo G
AU  -  de Moreuil C
AU  -  Del Giacco S
AU  -  Espigol-Frigole G
AU  -  Franceschini F
AU  -  Iorio L
AU  -  Kernder A
AU  -  Lo Gullo A
AU  -  Losappio L
AU  -  Manna E
AU  -  Maule M
AU  -  Milanesi A
AU  -  Montecucco C
AU  -  Negrini S
AU  -  Padoan R
AU  -  Regola F
AU  -  Ricciardi L
AU  -  Schroeder J
AU  -  Terrier B
AU  -  Toniati P
AU  -  Torracca F
AU  -  Treppo E
AU  -  Urban ML
AU  -  Vaglio A
AU  -  Emmi G
AU  -  Monti S
AU  -  European EGPA Study Group.
PY  - 2025
JO  - Rheumatology (Oxford)
DO  - 10.1093/rheumatology/keaf232
UR  - https://doi.org/10.1093/rheumatology/keaf232
ER  - 

APA

P, D., L, Q., JC, R., VV, F., C, K., F, A., D, B., A, B., M, C., M, C., MC, C., E, C., G, C., C, D. M., S, D. G., G, E., F, F., L, I., A, K., A, L. G., L, L., E, M., M, M., A, M., C, M., S, N., R, P., F, R., L, R., J, S., B, T., P, T., F, T., E, T., ML, U., A, V., G, E., S, M., & Group., E. E. S. (2025). Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaf232

Source records